Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.
- DOI
- 10.1007/s40264-026-01653-x
- Published
- 2026 Jul
- Container
- Drug safety
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40264-026-01653-x,
title = {Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.},
author = {Wang Y and Ewig CLY and Smolinski NE and Toyserkani GA and LaCivita C and Zhou EH and Dal Pan GJ and Thai TN and Maro JC and Rasmussen SA and Winterstein AG},
year = {2026},
journal = {Drug safety},
doi = {10.1007/s40264-026-01653-x},
url = {https://doi.org/10.1007/s40264-026-01653-x}
}RIS
TY - JOUR TI - Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool. AU - Wang Y AU - Ewig CLY AU - Smolinski NE AU - Toyserkani GA AU - LaCivita C AU - Zhou EH AU - Dal Pan GJ AU - Thai TN AU - Maro JC AU - Rasmussen SA AU - Winterstein AG PY - 2026 JO - Drug safety DO - 10.1007/s40264-026-01653-x UR - https://doi.org/10.1007/s40264-026-01653-x ER -
APA
Y, W., CLY, E., NE, S., GA, T., C, L., EH, Z., GJ, D. P., TN, T., JC, M., SA, R., & AG, W. (2026). Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.. Drug safety. https://doi.org/10.1007/s40264-026-01653-x
Source records
- pubmed · retrieved 2026-09-26T08:49:57.204Z